Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eisai
2
×
indiana blog main
indiana top stories
2
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
obamacare
2
×
purdue pharma
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
adaptive biotechnologies
aducanumab
affordable care act
aldeyra therapeutics
alex azar
alicrocumab
alzheimer's disease
american academy of neu
american academy of neurology
What
bio
biogen
roundup
week
2
×
aducanumab
alzheimer’s
america
amyloid
angst
bagged
billions
biogen’s
brammer
continues
convoluted
democrats
dreams
drug
effects
failure
felt
head
headaches
healthcare
holding
insurance
ipo
lost
moves
nash
news
previews
private
public
ripple
scrutiny
spine
suffer
Language
Current search:
eisai
×
week
×
" indiana top stories "
×
obamacare
×
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More